The Reality for Patients Using a GLP-1 and MDI GLP-1s have demonstrated substantial clinical benefits for many people with type 2 diabetes (T2D), but despite their growing use, many of these people have A1C levels that are greater than the 0.05
What makes us different
The decision to get B12 injections should be guided by lab results, honest risk-benefit discussions with a qualified provider, and clarity about whether you are treating a diagnosed deficiency or pursuing an elective wellness service
Approved Uses and Potential New Benefits Currently, GLP-1 receptor agonists are approved for managing diabetes, obesity, and cardiovascular disease in overweight individuals
Protocol Specifications: Daily Dose: 20-30 mcg Frequency: Once daily Best Timing: Post-workout OR before bed Injection Method: Subcutaneous (abdomen or thighs) Cycle Length: 4 weeks total Progressive Dosing Schedule: Week 1-2: 20 mcg/day (establish baseline tolerance) Week 3-4: 25-30 mcg/day (if no adverse effects observed) Expected Timeline: Most beginners notice improved recovery from workouts within 3-5 days as IGF-1 LR3 reduces muscle damage and accelerates repair
Semaglutide is the active ingredient in the brand-name medications Ozempic and Wegovy